62
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Correlations Between Coronary Artery Disease, Coronary Artery Calcium Score, and Lipoprotein(a) Level in Korea

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 981-987 | Received 12 May 2022, Accepted 20 Aug 2022, Published online: 07 Nov 2023

References

  • Utermann G. The mysteries of lipoprotein(a). Science. 1989;246(4932):904–910. doi:10.1126/science.2530631
  • Thanassoulis G, Campbell CY, Owens DS, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013;368(6):503–512. doi:10.1056/NEJMoa1109034
  • Kamstrup PR, Tybjærg-Hansen A, Nordestgaard BG. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol. 2014;63(5):470–477. doi:10.1016/j.jacc.2013.09.038
  • Nordestgaard BG, Langsted A. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. J Lipid Res. 2016;57(11):1953–1975. doi:10.1194/jlr.R071233
  • Nielsen LB. Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux. Atherosclerosis. 1999;143(2):229–243. doi:10.1016/S0021-9150(99)00064-7
  • Berglund L, Ramakrishnan R. Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol. 2004;24(12):2219–2226. doi:10.1161/01.ATV.0000144010.55563.63
  • Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2001;104(10):1108–1113. doi:10.1161/hc3501.095214
  • Virani SS, Brautbar A, Davis BC, et al. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2012;125(2):241–249. doi:10.1161/CIRCULATIONAHA.111.045120
  • Nordestgaard BG, Chapman MJ, Ray K, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31(23):2844–2853. doi:10.1093/eurheartj/ehq386
  • Torngren K, Rylance R, Björk J, et al. Association of coronary calcium score with endothelial dysfunction and arterial stiffness. Atherosclerosis. 2020;313:70–75. doi:10.1016/j.atherosclerosis.2020.09.022
  • Lo-Kioeng-Shioe MS, Rijlaarsdam-Hermsen D, van Domburg RT, et al. Prognostic value of coronary artery calcium score in symptomatic individuals: a meta-analysis of 34,000 subjects. Int J Cardiol. 2020;299:56–62. doi:10.1016/j.ijcard.2019.06.003
  • Cambillau M, Simon A, Amar J, et al. Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group. Arterioscler Thromb. 1992;12(11):1346–1352. doi:10.1161/01.ATV.12.11.1346
  • Mehta A, Vasquez N, Ayers CR, et al. Independent association of lipoprotein(a) and coronary artery calcification with atherosclerotic cardiovascular risk. J Am Coll Cardiol. 2022;79(8):757–768. doi:10.1016/j.jacc.2021.11.058
  • Shai I, Schulze MB, Manson JE, et al. A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes. Diabetologia. 2005;48(8):1469–1476. doi:10.1007/s00125-005-1814-3
  • Frohlich J, Dobiásová M, Adler L, et al. Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease. Physiol Res. 2004;53(5):481–486.
  • Qasim AN, Martin SS, Mehta NN, et al. Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women. Int J Cardiol. 2011;150(1):17–21. doi:10.1016/j.ijcard.2010.02.021
  • Burge MR, Eaton RP, Schade DS. The role of a coronary artery calcium scan in type 1 diabetes. Diabetes Technol Ther. 2016;18(9):594–603. doi:10.1089/dia.2016.0110
  • Chung YH, Lee B-K, Kwon HM, et al. Coronary calcification is associated with elevated serum lipoprotein (a) levels in asymptomatic men over the age of 45 years: a cross-sectional study of the Korean national health checkup data. Medicine. 2021;100(9):e24962. doi:10.1097/MD.0000000000024962
  • Sung KC, Wild SH, Byrne CD. Lipoprotein (a), metabolic syndrome and coronary calcium score in a large occupational cohort. Nutr Metab Cardiovasc Dis. 2013;23(12):1239–1246. doi:10.1016/j.numecd.2013.02.009
  • Enas A, Varkey B, Dharmarajan TS, et al. Lipoprotein(a): an independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction. Indian Heart J. 2019;71(2):99–112. doi:10.1016/j.ihj.2019.03.004
  • Nathan O. Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N Engl J Med. 2016;374(12):1134–1144.